Ocuphire Pharma, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
22.60
|
|
Average Rating
|
4.80
|
|
# Strong Buys
|
4
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.29
|
-0.22
|
0.07
|
24.14%
|
|
2022-06-30
|
-0.33
|
-0.25
|
0.08
|
24.24%
|
|
2022-03-31
|
-0.35
|
-0.35
|
0.00
|
0.00%
|
|
2021-12-31
|
-0.29
|
-0.35
|
-0.06
|
-20.69%
|
|
2021-09-30
|
-0.36
|
-0.25
|
0.11
|
30.56%
|
|
2021-06-30
|
-0.36
|
-0.52
|
-0.16
|
-44.44%
|
|
2021-03-31
|
-0.71
|
-3.57
|
-2.86
|
-402.82%
|
|
2020-12-31
|
-0.42
|
-4.18
|
-3.76
|
-895.24%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.82
|
|
2021-12-31
|
-4.69
|
|
2020-12-31
|
-5.28
|
|
2019-12-31
|
-8.74
|
|
2018-12-31
|
-21.60
|
|
2017-12-31
|
-12.00
|
|
2016-12-31
|
-0.30
|
|
2015-12-31
|
-0.62
|
|
2014-12-31
|
-8.73
|
|
2013-12-31
|
-17.28
|
|
2012-12-31
|
-31.96
|
|
2011-12-31
|
-13.20
|
|
2010-12-31
|
-47.51
|
|
2009-12-31
|
-32.22
|
|
2008-12-31
|
-42.28
|
|
2007-12-31
|
-41.05
|
|
2006-12-31
|
-64.58
|
|
2005-12-31
|
-1021.38
|
|
2004-12-31
|
-17760.00
|